GANX — Gain Therapeutics Share News
0.000.00%
Last trade - 00:00U.S. STOCKS ON THE MOVEX-Abbott, Columbia Financial, Jabil,
Gain Therapeutics climbs on narrower-than-expected quarterly loss
Gain Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Gain Therapeutics Q2 net loss per share narrows as R&D expenses fall
Gain Therapeutics Inc expected to post a loss of 14 cents a share - Earnings Preview
Brief: Gain Therapeutics Says MDS-UPDRS Scores Remain Stable After 150 Days Of GT-2287 Treatment
Gain Therapeutics Q1 loss per share narrows
NASDAQ RESUMED AT 10:13 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 10:03 AM
NASDAQ RESUMED AT 10:01 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:56 AM
NASDAQ RESUMED AT 09:56 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:41 AM
NASDAQ RESUMED AT 09:40 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:30 AM
Brief: Gain Therapeutics Files Prospectus For $35.5 Million Stock Sale - SEC Filing
U.S. RESEARCH ROUNDUP- Equifax, Johnson & Johnson, Morgan Stanley
U.S. RESEARCH ROUNDUP- BlackRock, Goldman Sachs, Netflix
Brief: Gain Therapeutics Begins Its Gt-02287 Phase 1b Extension Study In People With Parkinson’s Disease